BVNKF (Bavarian Nordic AS) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 25, 2026)


BVNKF Bavarian Nordic AS BVNKF
82 GF Score
Price $27.80
GF Value $25.88
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Bavarian Nordic AS Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Bavarian Nordic AS's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.


BVNKF vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Bavarian Nordic AS's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic AS Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic AS's Margin of Safety % (DCF FCF Based) falls into.


BVNKF
82GF Score
Bavarian Nordic AS BVNKF
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bavarian Nordic AS (BVNKF) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of $27.80 is trading 7.4% above its estimated GF Value™ of $25.88. GuruFocus considers Bavarian Nordic AS to be Fairly Valued.

Key valuation signals for BVNKF:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $25.88 vs. price of $27.80 (7.4% above fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the BVNKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bavarian Nordic AS Business Description

Address Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
82GF Score

Get the complete analysis for BVNKF

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.80
Price
$25.88
GF Value